EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Multigenetic Pharmacogenomics–Guided Treatment vs Treatment As Usual Among Hospitalized Men With Schizophrenia

Zhewei Kang, Ying Qin, Yutao Sun, Zhe Lu, Yaoyao Sun, Huan Chen, Xiaoyang Feng, Yuyanan Zhang, Hua Guo, Hao Yan, Weihua Yue

JAMA Network Open · 06.10.2023 · 6 (10) · e2335518

DOI: 10.1001/jamanetworkopen.2023.35518 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, online erschienen am 06.10.2023. Verfasst von Zhewei Kang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Mental Health, Peking University Sixth Hospital, Beijing, China. Hauptthemen laut MEDLINE: Pharmacogenetics, Schizophrenia. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Limited evidence supports multigenetic pharmacogenomics–guided treatment (MPGT) in schizophrenia.

Objective

To evaluate the clinical effectiveness of MPGT in schizophrenia in a randomized clinical trial (RCT). Design, Setting, and Participants This RCT was conducted from March 2020 to March 2022. Male Chinese Han inpatients aged 18 to 60 years diagnosed with schizophrenia with a Positive and Negative Symptom Scale (PANSS) score of 60 or more from 2 selected study hospitals were included. Patients and raters were masked to MPGT or treatment as usual (TAU) randomization.

Interventions

Participants were randomly assigned in a 1:1 ratio to receive either MPGT or TAU for 12 weeks. Main Outcomes and Measures The primary efficacy outcome was the percentage change in PANSS total scores (range, 30 to 210) from baseline to week 6 analyzed by a modified intention-to-treat mixed model for repeated measures. The secondary outcome included response and symptomatic remission rates.

Results

A total of 210 participants (mean [SD] age, 29.2 [8.8] years) were enrolled and analyzed, with 113 assigned to MPGT and 97 to TAU. Compared with those randomized to TAU, participants randomized to MPGT demonstrated a significantly higher percentage change in PANSS score (74.2% vs 64.9%; adjusted mean difference, 9.2 percentage points; 95% CI, 4.4-14.1 percentage points; P < .001) and a higher response rate (93 of 113 [82.3%] vs 63 of 97 [64.9%]; adjusted odds ratio, 2.48; 95% CI, 1.28-4.80; P = .01) at the end of week 6. Conclusions and Relevance In this RCT of MPGT, MPGT was more effective than TAU in treating patients with schizophrenia. These findings suggest that multigenetic pharmacogenomic testing could serve as an effective tool to guide the treatment of schizophrenia. Trial Registration Chinese Clinical Trial Registry Identifier: ChiCTR2000029671

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacogeneticsSchizophreniaMaleHumansAdultTreatment Outcome

Autor:innen und Institutionen

  • Institute of Mental Health, Peking University Sixth Hospital, Beijing, China.
  • National Clinical Research Center for Mental Disorders, Peking University Sixth Hospital, Beijing, China.
  • NHC Key Laboratory of Mental Health, Research Unit of Diagnosis and Treatment of Mood Cognitive Disorder, Chinese Academy of Medical Sciences, Beijing, China.
  • The Second People's Hospital of Guizhou Province, Guiyang, China.
  • Tangshan Mental Health Center, Tangshan Fifth Hospital, Tangshan, China.
  • Shantou University Mental Health Center, Shantou, China.

Zitieren

APA

Kang, Z., Qin, Y., Sun, Y., Lu, Z., Sun, Y., Chen, H., Feng, X., Zhang, Y., Guo, H., Yan, H., & Yue, W. (2023). Multigenetic Pharmacogenomics–Guided Treatment vs Treatment As Usual Among Hospitalized Men With Schizophrenia. JAMA Network Open, 6(10), e2335518. https://doi.org/10.1001/jamanetworkopen.2023.35518

Vancouver

Kang Z, Qin Y, Sun Y, Lu Z, Sun Y, Chen H, et al. Multigenetic Pharmacogenomics–Guided Treatment vs Treatment As Usual Among Hospitalized Men With Schizophrenia. JAMA Network Open. 2023;6(10):e2335518. doi:10.1001/jamanetworkopen.2023.35518

BibTeX
@article{Kang2023,
  author = {Kang, Zhewei and Qin, Ying and Sun, Yutao and Lu, Zhe and Sun, Yaoyao and Chen, Huan and Feng, Xiaoyang and Zhang, Yuyanan and Guo, Hua and Yan, Hao and Yue, Weihua},
  title = {Multigenetic Pharmacogenomics–Guided Treatment vs Treatment As Usual Among Hospitalized Men With Schizophrenia},
  journal = {JAMA Network Open},
  year = {2023},
  volume = {6},
  number = {10},
  pages = {e2335518},
  doi = {10.1001/jamanetworkopen.2023.35518}
}
Kostenlos starten →